Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus

Summary

Examination of the effect of Linagliptin versus placebo on diastolic function in patients with type 2 diabetes mellitus and diastolic dysfunction as assessed by transthoracic echocardiography. Furthermore the effect on serum levels of NT-pro BNP as a biomarker of heart failure will be investigated.

Timeline

Start

2013-09

Primary completion

2014-12

Completion

2014-12

Drugs

Indications